Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Aran Research & Development (1982) Ltd. (ARAN.TA)
Caesarea, IL
Aran Research & Development (1982) Ltd., an Israeli company founded in Caesarea in 1982, specializes in the design, development, and manufacturing of various products and equipment, with a significant focus on the plastics industry within Israel. The company boasts a broad portfolio, encompassing a wide array of medical devices such as cardiovascular solutions, in-vitro diagnostic tools, surgical instruments, and advanced imaging and monitoring systems. They are also prominent in fluid management, producing water devices like pressure and flow regulators, a variety of valves (electric, hydraulic, air release, check), sprinklers, drippers, taps, water meters, filters, electronic controllers, and specialized testing equipment. Beyond these core areas, Aran provides portable and stationary control systems for unmanned platforms, electro-optical technologies, and robust electronic hardware engineered for demanding ground, marine, and aerial environments. Their offerings extend to ground systems for security and access control, test and measurement equipment, and production line facilities. The company further manufactures specialized printers, automatic beverage dispensers, sophisticated retail technology like computerized shopping carts and self-checkout kiosks, industrial and communication devices, and batteries. Additionally, Aran acts as a supplier for crucial machinery and components, including injection molding machines, robotics and automation systems, injection molds, hot runner systems, drying, dosing, and conveying systems, plasticizing screws and barrels, and ultrasonic welding and cleaning equipment, along with raw materials. The firm also delivers comprehensive support services and makes strategic investments in emerging medical technology startups.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.48% | -1.30% | +8.72% | +5.80% | +50.83% | +15.36% | +46.51% | +115.86% | +116.72% | +49.07% | +1,522.80% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Conglomerates: +6.1%+20.8% ★ Q4'25: +122.8% (vs Q3'24)
-
EPS growth Conglomerates: +16.9%+192.1% ★ Q4'25: +471.4% (vs Q3'24)
-
FCF margin FCF growth · Conglomerates: +35.9%+21.4% ★ Q4'25: +30.2% (vs Q3'24)
-
EBIT margin Conglomerates: +9.0%+6.2% Q4'25: +5.1% (vs Q3'24)
-
ROIC Conglomerates: +4.7%+16.1% ★ Q4'25: +26.3% (vs Q3'24)
-
Share dilution Conglomerates: +0.0%-6.4% ★ Q4'25: -6.7% (vs Q3'24)
-
Debt / EBITDA Net debt/EBITDA · Conglomerates: 1.28×1.13× ★ Q4'25: 0.64× (vs Q3'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-25 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-15 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-04 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-01 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Avi Posen | Vice President of Sales | 857.0K | — |
| Etti Rosenberg | Vice President of Human Resources | 806.0K | female |
| Arie Tolman | Vice President of Marketing | 648.0K | — |
| Orit Beckerman | Chief Financial Officer & Company Secretary | 627.0K | female |
| Ran Stav | Chief Executive Officer & Director | 236.0K | male |
| Dror Peintoch | Group Accountant | — | — |
| Gilad Hokman | Chief Executive Officer of Aran Software | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ARAN.TA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
